Skip to main content
MBAI
NASDAQ Technology

MBody AI Sets Dec 22 AGM: 175M Share Authorization, 1.84M-Share Equity Plan, New External Directors

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.115
Mkt Cap
$32.346M
52W Low
$1.611
52W High
$27.44
52W Position info
31% above low
Off High info
92% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

MBAI sits 31% above its 52-week low of $1.611 on light trading volume (0.3× avg).

Summary

MBody AI's first post-merger annual meeting asks shareholders to expand authorized shares from 18 million to 175 million, adopt a 1.84-million-share equity plan, elect two external directors required by its new controlling shareholder, and approve CEO and director pay.


Key Events · Corporate Governance and Compliance · MBAI

  • Authorized Shares to Rise to 175 Million

    Proposal 2 would lift authorized capital from 18,000,000 to 175,000,000 Ordinary Shares, conditional on the no-par-value amendment in Proposal 1. That leaves roughly 157.7 million authorized-but-unissued shares after the meeting — a multi-year capacity for financings and acquisitions, and a standing dilution overhang rather than shares actually sold.

  • Equity Plan Reserves 12% of Shares

    The 2026 Equity Incentive Plan reserves 1,841,517 Ordinary Shares, about 12% of the 15,345,971 shares outstanding as of November 13, 2026. The reserve is fixed with no evergreen feature; the prior 2015 plan expired June 23, 2025.

  • Two External Directors Required

    Because Chairman Regan McGee holds approximately 45% and is a controlling shareholder, the Nasdaq exemption from Israeli external-director rules ended at the August 26, 2026 closing. Fiona George and Daniel Kokiw are nominated; if they fail, the board falls below its four-director minimum and Proposals 8 and 9 cannot be voted.

  • CEO Pay: $375,000 Base Plus 150% Bonus

    John Fowler's terms set a US$375,000 base salary, bonus up to 150% of base, a US$112,500 sign-on bonus, 12 months' severance and a parent guarantee of the MBody AI Corp. employment agreement. No equity grant is proposed at this meeting.


Analysis · MBAI · Technology

This is the first shareholder meeting since the August 26, 2026 merger, and it bundles the governance housekeeping the deal left undone with a large expansion of the share authorization. The headline item is raising authorized capital from 18,000,000 to 175,000,000 shares — roughly 157.7 million shares of headroom against 15,345,971 outstanding, which gives the Board room for years of financings and acquisitions without another vote. That is a standing dilution overhang, not dilution that has occurred. Alongside it, the 2026 Equity Incentive Plan reserves 1,841,517 shares (about 12% of the current count), and the company must elect two external directors because Chairman Regan McGee's ~45% stake made it a controlled company and killed its Nasdaq exemption. The two-session structure exists because Israeli law requires the new external directors to sit on the compensation committee before shareholders can vote on pay. Failure of the external-director vote would leave the board below its four-director minimum and force a follow-up meeting.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MBAI was trading at $2.12 on NASDAQ in the Technology sector, with a market capitalization of approximately $32.3M. The 52-week trading range was $1.61 to $27.44. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MBAI - Latest Insights

MBAI
Sep 29, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.10
Real-time Price: $2.12 info
Change: -$1.98 (-48%) info
Market Cap: $32.346M info
MBAI
Sep 22, 2026, 5:27 PM EDT
Filing Type: F-3
Importance Score:
7
Price at Filing: $6.38
Real-time Price: $2.12 info
Change: -$4.27 (-67%) info
Market Cap: $32.346M info
MBAI
Sep 22, 2026, 5:13 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $6.38
Real-time Price: $2.12 info
Change: -$4.27 (-67%) info
Market Cap: $32.346M info
MBAI
Sep 16, 2026, 8:35 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.69
Real-time Price: $2.12 info
Change: -$4.58 (-68%) info
Market Cap: $32.346M info
MBAI
Aug 28, 2026, 4:03 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.58
Real-time Price: $2.12 info
Change: -$4.47 (-68%) info
Market Cap: $32.346M info